Security key
G1281K114
Silexion Therapeutics Corp - Ordinary shares, par value $0.135 per share (SLXNW)
CUSIP: G1281K114
Q3 2025 13F Holders as of 30 Sep 2025
- Security type / class
- Equity / Ordinary shares, par value $0.135 per share
- Total 13F shares
- 2,563,892
- Total 13F value
- $127,540
- Share change
- -99,102
- SEC-reported price per share
- $0.04
- Number of holders
- 22
- Value change
- +$33,022
- Number of buys
- 3
- Number of sells
- 1
Report period
Q3 2025
Institutions
22
Top holders
10
SLXNW full security history
Ownership snapshot
Full 13F holder table
Silexion Therapeutics Corp SEC filings
Silexion Therapeutics Corp company facts
Broader feeds
Ownership snapshot
Top reported holders of SLXNW - Silexion Therapeutics Corp - Ordinary shares, par value $0.135 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
Lind Global Fund III LP
Disclosed value leader
Ilan Levin
Comparable rows
13/15
Latest evidence
30 Sep 2025
13D/G
13F
3/4/5
Lead comparable stake: 6.4%
2 rows are not safely comparable across share classes.
13D/G row: Lind Global Fund III LP
Showing 1-6 of 15 holder rows.
Quick read
Lind Global Fund III LP leads the comparable SEC ownership view at 6.4%.
13 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens Lind Global Fund III LP's linked filing trail.
Comparable ownership
Top 5
Lind Global Fund III LP
6.4%
Lincoln Alternative Strategies LLC
6.2%
INTRACOASTAL CAPITAL, LLC
5%
Orca Capital AG
4.9%
CVI Investments, Inc.
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| Lind Global Fund III LP |
13D/G
|
6.4%
|
$187,000
212,500 shares
|
-$10,164 | 30 Sep 2025 |
| Lincoln Alternative Strategies LLC |
13D/G
|
6.2%
|
$115,500
131,250 shares
|
$0 | 12 Sep 2025 |
| INTRACOASTAL CAPITAL, LLC |
13D/G
Mitchell P. Kopin
|
5%
|
$195,139
209,827 shares
|
$0 | 15 Jan 2025 |
| Orca Capital AG |
13D/G
|
4.9%
|
$802,137
109,432 shares
|
$0 | 11 Sep 2025 |
| CVI Investments, Inc. |
13D/G
|
4.9%
|
$424,574
456,531 shares
|
+$109,304 | 31 Mar 2025 |
| GOLDMAN SACHS GROUP INC |
13D/G
13F
THE GOLDMAN SACHS GROUP, INC. · Company
|
2.4%
|
$197,109
211,945 shares
|
+$92,724 | 31 Mar 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q3 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
22
Shares
2,563,892
Rows available
22
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q3 2025 vs Q2 2025 Across Filers
Q2 2025 holders
22
Q3 2025 holders
22
Holder diff
0
| Investor | Q2 2025 Shares | Q3 2025 Shares | Share Diff | Share Chg % | Q2 2025 value | Q3 2025 value | Value change | Value Chg % |
|---|